Latest Distributions News

Ramelius Resources has finalized its acquisition of Spartan Resources through a scheme of arrangement, leading to Spartan’s delisting from the ASX and share transfers to Ramelius shareholders.

Medical Developments International (MVP) reports positive operating cash flow in H2 FY25, driven by strong Penthrox sales and strategic distribution shifts in Europe. The company eyes further growth amid regulatory progress and efficiency gains.

ClearVue Technologies has announced a major leadership overhaul alongside strategic partnerships and market expansion, highlighted by a solar façade trial in Hong Kong demonstrating a payback period as low as 2.6 years.

Alcoa Corporation has announced a quarterly dividend of USD 0.10 per security, payable on August 28, 2025, with a 30% U.S. withholding tax applying by default. Shareholders have multiple currency payment options depending on their residency and banking details.

Starpharma reports a 165% rise in FY25 customer receipts, advances its clinical-stage DEP® assets, and secures new distribution deals in Asia and Saudi Arabia.

Burgundy Diamond Mines has updated its Ekati Diamond Mine Life of Mine plan through 2040, extending Misery underground operations and advancing the Fox Underground project with strong economic prospects.

Associate Global Partners Limited reported an 11% increase in funds under management to $1.397 billion for the June quarter 2025, alongside sustained positive operating cash flows and strong fund performance from its WCM strategies.

Alma Metals has bolstered its Briggs Copper JV Project with a $1.06 million capital raise and an updated resource estimate that now includes silver. The company is progressing a scoping study and preparing for significant drilling to unlock further value.

Iltani Resources has announced its maiden JORC Mineral Resource Estimate for the Orient West Silver-Indium deposit, revealing a significant 21.6 million tonnes at 100.5 g/t silver equivalent. This milestone confirms the project as Australia's largest known silver-indium resource and sets the stage for further expansion.

EVE Health Group has completed its acquisition of Nextract, raised $1 million to fund manufacturing, and achieved key regulatory and commercial milestones for its pharmaceutical products targeting erectile dysfunction and dysmenorrhea.

xReality Group delivered a strong Q4 FY25 with $4.7 million in cash receipts, driven by growth in its Operator XR enterprise software and entertainment divisions, alongside a $2 million placement to institutional investors supporting international expansion.

Cluey Ltd has achieved its first-ever positive operating cash flow in Q4 FY25, marking a pivotal shift towards sustainable growth powered by AI innovation and expanded market reach.